UBS Group’s Protagenic Therapeutics, Inc. Warrant PTIXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,000
| Closed | -$21 | – | 9262 |
|
|
2025
Q1 | $21 | Buy |
3,000
+2,640
| +733% | +$18 | ﹤0.01% | 8771 |
|
|
2024
Q4 | $1 | Buy |
+360
| New | +$1 | ﹤0.01% | 8615 |
|
|
2024
Q1 | – | Sell |
-100
| Closed | -$1 | – | 8528 |
|
|
2023
Q4 | $1 | Buy |
+100
| New | +$1 | ﹤0.01% | 7992 |
|
|
2022
Q4 | – | Sell |
-108
| Closed | – | – | 9743 |
|
|
2022
Q3 | $0 | Hold |
108
| – | – | ﹤0.01% | 9588 |
|
|
2022
Q2 | $0 | Hold |
108
| – | – | ﹤0.01% | 9614 |
|
|
2022
Q1 | $0 | Buy |
+108
| New | – | ﹤0.01% | 9517 |
|
|
2021
Q4 | – | Sell |
-600
| Closed | – | – | 9329 |
|
|
2021
Q3 | $0 | Buy |
+600
| New | – | ﹤0.01% | 8684 |
|